Tacrolimus Pharmacokinetics is Associated with Gut Microbiota Diversity in Kidney Transplant Patients: Results from a Pilot Cross‐Sectional Study
暂无分享,去创建一个
V. Haufroid | L. Bindels | L. Elens | L. Boland | Kévin-Alexandre Delongie | Alexandra L. Degraeve | Djamila Chaib Eddour | Serge Moudio | Joseph P. Dewulf | Michel Mourad
[1] V. Haufroid,et al. Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1 , 2023, Microbiome.
[2] K. Attwood,et al. Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities , 2023, Clinical and translational science.
[3] Sylwester Drożdżal,et al. The Effect of the Gut Microbiota on Transplanted Kidney Function , 2023, International journal of molecular sciences.
[4] Ruoying Li,et al. Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection , 2022, Journal of translational medicine.
[5] Ethan Loew,et al. Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epithelium That Directs P-Glycoprotein Expression , 2022, mBio.
[6] N. Chattipakorn,et al. Impact of gut microbiota on kidney transplantation. , 2021, Transplantation reviews.
[7] Ana Rita Brochado,et al. Bioaccumulation of therapeutic drugs by human gut bacteria , 2021, Nature.
[8] Patrice D Cani,et al. Multi‐compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice , 2021, Journal of cachexia, sarcopenia and muscle.
[9] P. Marquet,et al. Tacrolimus Exposure Prediction Using Machine Learning , 2020, Clinical pharmacology and therapeutics.
[10] G. Tsiamis,et al. Impact of the Post-Transplant Period and Lifestyle Diseases on Human Gut Microbiota in Kidney Graft Recipients , 2020, Microorganisms.
[11] D. Taber,et al. Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management , 2020, Pharmacotherapy.
[12] N. Takahashi,et al. Nitrite Production from Nitrate and Its Link with Lactate Metabolism in Oral Veillonella spp , 2020, Applied and Environmental Microbiology.
[13] Å. Keita,et al. The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability , 2020, Cells.
[14] V. Haufroid,et al. Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives , 2020, Expert opinion on drug metabolism & toxicology.
[15] R. Nandakumar,et al. Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation , 2020, PloS one.
[16] D. DuBay,et al. A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] Zhaoli Sun,et al. Butyric acid normalizes hyperglycemia caused by the tacrolimus‐induced gut microbiota , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] E. L. Rosado,et al. Profile of the gut microbiota of adults with obesity: a systematic review , 2020, European Journal of Clinical Nutrition.
[19] O. Tenaillon,et al. Gut microbiota composition alterations are associated with the onset of diabetes in kidney transplant recipients , 2020, PloS one.
[20] Y. Taur,et al. Butyrate‐producing gut bacteria and viral infections in kidney transplant recipients: A pilot study , 2019, Transplant infectious disease : an official journal of the Transplantation Society.
[21] A. Goodman,et al. Mapping human microbiome drug metabolism by gut bacteria and their genes , 2019, Nature.
[22] U. Christians,et al. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report , 2019, Therapeutic drug monitoring.
[23] B. Guida,et al. Nutritional management in renal transplant recipients: A transplant team opportunity to improve graft survival. , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[24] L. Rostaing,et al. An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization , 2019, Expert opinion on drug safety.
[25] B. Griffin,et al. Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions , 2019, Pharmacological Reviews.
[26] T. Hori,et al. Draft Genome Sequence of a Novel Lactate-Fermenting Bacterial Strain of the Family Sporomusaceae within the Class Negativicutes , 2019, Microbiology Resource Announcements.
[27] J. D. de Fijter,et al. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients , 2019, British journal of clinical pharmacology.
[28] Y. Taur,et al. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[29] I. Yakoub-Agha,et al. Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[30] Luis Pedro Coelho,et al. Towards standards for human fecal sample processing in metagenomic studies , 2017, Nature Biotechnology.
[31] H. Colom,et al. The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation , 2017, Pharmacogenetics and genomics.
[32] N. Galante,et al. OriginalClinicalScienceçGeneral Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation , 2017 .
[33] Paul J. McMurdie,et al. Exact sequence variants should replace operational taxonomic units in marker-gene data analysis , 2017, The ISME Journal.
[34] S. Ohtsuki,et al. Effect of Intestinal Flora on Protein Expression of Drug-Metabolizing Enzymes and Transporters in the Liver and Kidney of Germ-Free and Antibiotics-Treated Mice. , 2016, Molecular pharmaceutics.
[35] Morris A. Swertz,et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity , 2016, Science.
[36] J. Raes,et al. Population-level analysis of gut microbiome variation , 2016, Science.
[37] Markus Quante,et al. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation , 2015, Transplantation.
[38] Nora C. Toussaint,et al. Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation , 2015, PloS one.
[39] Nora C. Toussaint,et al. Gut Microbial Community Structure and Complications After Kidney Transplantation: A Pilot Study , 2014, Transplantation.
[40] W. F. Fricke,et al. Human Microbiota Characterization in the Course of Renal Transplantation , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[41] V. Haufroid,et al. Impact of CYP3A4*22 Allele on Tacrolimus Pharmacokinetics in Early Period After Renal Transplantation: Toward Updated Genotype-Based Dosage Guidelines , 2013, Therapeutic drug monitoring.
[42] A. Åsberg,et al. Importance of hematocrit for a tacrolimus target concentration strategy , 2013, European Journal of Clinical Pharmacology.
[43] A. Israni,et al. Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[44] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[45] Katherine H. Huang,et al. Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.
[46] Harry J. Flint,et al. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. , 2009, FEMS microbiology letters.
[47] J. Squifflet,et al. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients. , 2004, Pharmacogenetics.
[48] L. Forney,et al. Distribution of bacterioplankton in meromictic Lake Saelenvannet, as determined by denaturing gradient gel electrophoresis of PCR-amplified gene fragments coding for 16S rRNA , 1997, Applied and environmental microbiology.
[49] Identi fi cation and Characterization of Major Bile Acid 7 a -Dehydroxylating Bacteria in the Human Gut , 2022 .